NDUFB11 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	41 studies	45% ± 14%	Explore
natural killer cell	36 studies	45% ± 15%	Explore
fibroblast	34 studies	44% ± 17%	Explore
CD8-positive, alpha-beta T cell	34 studies	47% ± 20%	Explore
macrophage	33 studies	44% ± 14%	Explore
T cell	30 studies	46% ± 17%	Explore
CD4-positive, alpha-beta T cell	30 studies	51% ± 17%	Explore
endothelial cell	29 studies	41% ± 16%	Explore
pericyte	28 studies	45% ± 15%	Explore
conventional dendritic cell	27 studies	58% ± 15%	Explore
regulatory T cell	26 studies	49% ± 15%	Explore
classical monocyte	25 studies	53% ± 16%	Explore
smooth muscle cell	24 studies	44% ± 15%	Explore
plasmacytoid dendritic cell	24 studies	57% ± 15%	Explore
plasma cell	23 studies	59% ± 22%	Explore
non-classical monocyte	22 studies	51% ± 15%	Explore
dendritic cell	21 studies	49% ± 24%	Explore
epithelial cell	21 studies	55% ± 22%	Explore
memory B cell	19 studies	48% ± 9%	Explore
basal cell	19 studies	52% ± 20%	Explore
connective tissue cell	19 studies	45% ± 21%	Explore
gamma-delta T cell	18 studies	45% ± 15%	Explore
mature NK T cell	18 studies	42% ± 12%	Explore
naive B cell	18 studies	40% ± 10%	Explore
mast cell	17 studies	38% ± 14%	Explore
monocyte	17 studies	52% ± 10%	Explore
endothelial cell of lymphatic vessel	16 studies	49% ± 13%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	47% ± 13%	Explore
mucosal invariant T cell	15 studies	42% ± 14%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	44% ± 14%	Explore
ciliated cell	15 studies	49% ± 19%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	41% ± 14%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	54% ± 12%	Explore
myofibroblast cell	13 studies	51% ± 15%	Explore
myeloid cell	13 studies	48% ± 19%	Explore
plasmablast	12 studies	67% ± 19%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	46% ± 20%	Explore
capillary endothelial cell	12 studies	32% ± 16%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	46% ± 20%	Explore
secretory cell	11 studies	55% ± 19%	Explore
endothelial cell of artery	11 studies	35% ± 15%	Explore
vein endothelial cell	11 studies	37% ± 17%	Explore
innate lymphoid cell	10 studies	41% ± 12%	Explore
progenitor cell	10 studies	65% ± 20%	Explore
abnormal cell	10 studies	54% ± 21%	Explore
goblet cell	10 studies	49% ± 21%	Explore
endothelial cell of vascular tree	10 studies	31% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	48% ± 15%	Explore
mesothelial cell	9 studies	50% ± 17%	Explore
type I pneumocyte	8 studies	47% ± 17%	Explore
type II pneumocyte	8 studies	56% ± 22%	Explore
leukocyte	8 studies	45% ± 14%	Explore
IgG plasma cell	8 studies	42% ± 16%	Explore
T follicular helper cell	8 studies	47% ± 9%	Explore
club cell	7 studies	59% ± 8%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	58% ± 21%	Explore
epithelial cell of proximal tubule	7 studies	49% ± 17%	Explore
neuron	7 studies	55% ± 29%	Explore
enterocyte	7 studies	42% ± 14%	Explore
IgA plasma cell	7 studies	42% ± 17%	Explore
hematopoietic precursor cell	6 studies	54% ± 25%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	61% ± 23%	Explore
kidney loop of Henle epithelial cell	6 studies	50% ± 12%	Explore
renal alpha-intercalated cell	6 studies	76% ± 5%	Explore
intestinal crypt stem cell	6 studies	47% ± 24%	Explore
hematopoietic stem cell	6 studies	64% ± 15%	Explore
brush cell	6 studies	38% ± 19%	Explore
erythrocyte	6 studies	48% ± 24%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	56% ± 19%	Explore
alveolar macrophage	5 studies	43% ± 5%	Explore
CD4-positive helper T cell	5 studies	34% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	40% ± 14%	Explore
exhausted T cell	5 studies	62% ± 13%	Explore
ionocyte	5 studies	48% ± 11%	Explore
respiratory goblet cell	5 studies	52% ± 21%	Explore
platelet	5 studies	24% ± 8%	Explore
mononuclear phagocyte	5 studies	54% ± 15%	Explore
neutrophil	5 studies	29% ± 6%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	73% ± 9%	Explore
enteroendocrine cell	5 studies	65% ± 23%	Explore
transit amplifying cell	5 studies	57% ± 22%	Explore
retinal rod cell	5 studies	36% ± 18%	Explore
precursor B cell	5 studies	46% ± 13%	Explore
T-helper 17 cell	5 studies	56% ± 20%	Explore
immature B cell	5 studies	58% ± 11%	Explore
double negative thymocyte	5 studies	59% ± 14%	Explore
intermediate monocyte	5 studies	66% ± 12%	Explore
granulocyte	5 studies	39% ± 15%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	43% ± 16%	Explore
pancreatic A cell	4 studies	71% ± 9%	Explore
type B pancreatic cell	4 studies	58% ± 14%	Explore
glomerular endothelial cell	4 studies	33% ± 9%	Explore
retinal ganglion cell	4 studies	66% ± 22%	Explore
retinal cone cell	4 studies	60% ± 23%	Explore
erythroblast	4 studies	53% ± 21%	Explore
pro-B cell	4 studies	50% ± 16%	Explore
amacrine cell	4 studies	43% ± 19%	Explore
astrocyte	4 studies	37% ± 15%	Explore
retina horizontal cell	4 studies	37% ± 20%	Explore
adventitial cell	4 studies	32% ± 3%	Explore
mucus secreting cell	4 studies	46% ± 22%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	55% ± 10%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	55% ± 25%	Explore
deuterosomal cell	3 studies	35% ± 9%	Explore
duct epithelial cell	3 studies	56% ± 9%	Explore
precursor cell	3 studies	74% ± 12%	Explore
pancreatic D cell	3 studies	64% ± 18%	Explore
podocyte	3 studies	60% ± 11%	Explore
neural crest cell	3 studies	69% ± 5%	Explore
retinal bipolar neuron	3 studies	48% ± 22%	Explore
OFF-bipolar cell	3 studies	45% ± 25%	Explore
ON-bipolar cell	3 studies	47% ± 24%	Explore
renal principal cell	3 studies	67% ± 5%	Explore
extravillous trophoblast	3 studies	62% ± 13%	Explore
placental villous trophoblast	3 studies	71% ± 14%	Explore
lymphocyte	3 studies	59% ± 17%	Explore
neuroendocrine cell	3 studies	65% ± 25%	Explore
microglial cell	3 studies	35% ± 11%	Explore
serous secreting cell	3 studies	58% ± 5%	Explore
intraepithelial lymphocyte	3 studies	48% ± 17%	Explore
Mueller cell	3 studies	41% ± 12%	Explore
rod bipolar cell	3 studies	41% ± 16%	Explore
acinar cell	3 studies	38% ± 7%	Explore
muscle cell	3 studies	42% ± 19%	Explore
germinal center B cell	3 studies	54% ± 3%	Explore
myoepithelial cell	3 studies	47% ± 7%	Explore
inflammatory macrophage	3 studies	35% ± 7%	Explore
luminal cell of prostate epithelium	3 studies	39% ± 9%	Explore
IgM plasma cell	3 studies	57% ± 10%	Explore
granulocyte monocyte progenitor cell	3 studies	62% ± 25%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	64% ± 33%	Explore
glial cell	3 studies	50% ± 23%	Explore
hepatocyte	3 studies	61% ± 29%	Explore
group 3 innate lymphoid cell	3 studies	54% ± 18%	Explore
keratinocyte	3 studies	46% ± 3%	Explore
T-helper 1 cell	3 studies	62% ± 17%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	55% ± 11%	Explore
double-positive, alpha-beta thymocyte	3 studies	68% ± 8%	Explore
progenitor cell of mammary luminal epithelium	3 studies	59% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	19 studies	50% ± 14%	Explore
lung	17 studies	50% ± 17%	Explore
intestine	13 studies	43% ± 19%	Explore
kidney	9 studies	46% ± 13%	Explore
eye	8 studies	36% ± 16%	Explore
brain	6 studies	29% ± 8%	Explore
liver	6 studies	43% ± 22%	Explore
pancreas	5 studies	52% ± 20%	Explore
bone marrow	5 studies	34% ± 17%	Explore
lymph node	5 studies	58% ± 14%	Explore
placenta	4 studies	51% ± 23%	Explore
uterus	4 studies	55% ± 17%	Explore
prostate	4 studies	30% ± 9%	Explore
breast	4 studies	45% ± 8%	Explore
adrenal gland	3 studies	45% ± 10%	Explore
skin	3 studies	31% ± 11%	Explore
thymus	3 studies	62% ± 27%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	3429.77	1445 / 1445	100%	200.02	183 / 183
liver	100%	3343.34	226 / 226	100%	340.59	406 / 406
ovary	100%	2358.82	180 / 180	100%	504.65	430 / 430
pancreas	100%	2863.33	328 / 328	100%	274.06	178 / 178
skin	100%	3375.40	1809 / 1809	100%	317.64	472 / 472
thymus	100%	4756.36	653 / 653	100%	392.80	604 / 605
uterus	100%	2594.14	170 / 170	100%	455.85	458 / 459
brain	100%	3318.32	2636 / 2642	100%	329.89	705 / 705
kidney	100%	4220.79	89 / 89	99%	237.86	896 / 901
intestine	100%	3595.58	966 / 966	99%	347.86	524 / 527
prostate	100%	3666.48	245 / 245	99%	387.13	499 / 502
stomach	100%	3485.55	359 / 359	99%	318.47	284 / 286
adrenal gland	100%	5581.83	258 / 258	99%	408.77	228 / 230
bladder	100%	2991.33	21 / 21	99%	377.77	498 / 504
breast	100%	2944.73	459 / 459	99%	317.03	1104 / 1118
lung	100%	2885.34	576 / 578	99%	280.55	1143 / 1155
eye	0%	0	0 / 0	100%	348.84	80 / 80
lymph node	0%	0	0 / 0	100%	597.11	29 / 29
muscle	100%	8651.54	803 / 803	0%	0	0 / 0
spleen	100%	3470.53	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	393.01	45 / 45
ureter	0%	0	0 / 0	100%	197.99	1 / 1
adipose	100%	2860.01	1202 / 1204	0%	0	0 / 0
blood vessel	100%	2954.04	1331 / 1335	0%	0	0 / 0
heart	99%	6142.87	855 / 861	0%	0	0 / 0
peripheral blood	98%	2752.18	908 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	NDUFB11
Protein name	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3)
Synonyms	UNQ111/PRO1064
Description	FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. . FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. . FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. . FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. . FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. .
Accessions	Q9NX14 ENST00000688286.1 ENST00000690053.1 A0A8I5KTD1 ENST00000276062.9 ENST00000692649.1 A0A8I5KQF7 A0A8I5KTJ9 ENST00000687244.1 [Q9NX14-2] A0A8J8YU24 ENST00000377811.4 [Q9NX14-1]

GO_0009060	Biological process	aerobic respiration
GO_0042776	Biological process	proton motive force-driven mitochondrial ATP synthesis
GO_0032981	Biological process	mitochondrial respiratory chain complex I assembly
GO_0045271	Cellular component	respiratory chain complex I
GO_0005743	Cellular component	mitochondrial inner membrane
GO_0005739	Cellular component	mitochondrion
GO_0005515	Molecular function	protein binding

NDUFB11 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review